1-3 of 3
Dana Cullen
Close
Sort by
Journal Articles

Oxidative Stress-Mediated Activation of AKT/mTOR Signaling Pathway Leads to Myeloproliferative Syndrome in FoxO3 Null Mice: A Role for Lnk Adaptor Protein

Safak Yalcin, Sathish Kumar Mungamuri, Dragan Marinkovic, Xin Zhang, Wei Tong, PhD, Dana Cullen, Saghi Ghaffari, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 509.
https://doi.org/10.1182/blood.V112.11.509.509
Published: 2008
Journal Articles

JAK2 T875N is a novel activating mutation that results in myeloproliferative disease with features of megakaryoblastic leukemia in a murine bone marrow transplantation model

Thomas Mercher, Gerlinde Wernig, Sandra A. Moore, Ross L. Levine, Ting-Lei Gu, Stefan Fröhling, Dana Cullen, Roberto D. Polakiewicz, Olivier A. Bernard, Titus J. Boggon, Benjamin H. Lee, D. Gary Gilliland
Journal: Blood
Blood (2006) 108 (8): 2770–2779.
https://doi.org/10.1182/blood-2006-04-014712
Published: 2006
Includes: Supplemental data
Journal Articles

The small molecule tyrosine kinase inhibitor AMN107 inhibits TEL-PDGFRβ and FIP1L1-PDGFRα in vitro and in vivo

Elizabeth H. Stover, Jing Chen, Benjamin H. Lee, Jan Cools, Elizabeth McDowell, Jennifer Adelsperger, Dana Cullen, Allison Coburn, Sandra A. Moore, Rachel Okabe, Doriano Fabbro, Paul W. Manley, James D. Griffin, D. Gary Gilliland
Journal: Blood
Blood (2005) 106 (9): 3206–3213.
https://doi.org/10.1182/blood-2005-05-1932
Published: 2005